Research October 08, 2021 Deciphering Mexican genome: challenge of oriGen project The oriGen project, an initiative TecSalud is participating in, hopes to crack the Mexican genome by studying 100,000 people to determine the genetic components associated with the population’s most common diseases.
Education August 16, 2021 How are the Mexican media doing? Report by Tec, WAN-IFRA, and Facebook A study carried out by Tec de Monterrey, the World Association of News Publishers, and Facebook Journalism Project has found that 85% of media outlets plan to modify their business model.
Health July 01, 2021 Study shows CureVac vaccine is 100% effective against death from COVID Phase 3 study results have shown that the German CureVac vaccine is 100% effective at preventing hospitalization or death from any variant of the COVID-19 virus.
Institution June 14, 2021 EGADE joins association of world’s leading business schools The Graduate Management Admission Council (GMAC) has welcomed Tecnológico de Monterrey’s EGADE Business School as a member of this association.
Research June 10, 2021 CureVac vaccine protocol: public-private collaboration success story Clinical trials for the CureVac vaccine carried out by private institutions such as TecSalud and the Mexican government have made public-private synergy necessary.
Research May 11, 2021 TecSalud will develop a protocol for cell therapy against COVID-19 TecSalud and NovocellBio signed a collaboration agreement to start the NK (natural killer) immune cell culture protocol.
Health May 03, 2021 Mexican CureVac vaccine studies move ahead with TecSalud TecSalud demonstrates research leadership by participating in the German CureVac COVID-19 vaccine clinical trial.
Entrepreneurs March 05, 2021 Tec project promoting education given awards by IBM and Microsoft A Tec de Monterrey student platform that uses algorithms to suggest options for new educational experiences wins first place in the IBM Call for Code Latin America and the Microsoft Future of Work competitions.
Health February 17, 2021 TecSalud begins Phase 3 trials of German CureVac vaccine in Mexico TecSalud has started administering the vaccine candidate from German pharmaceutical company CureVac for its Phase 3 clinical trials.
Health January 11, 2021 TecSalud to begin testing German vaccine against COVID-19 in Mexico TecSalud, Tec de Monterrey’s health system, has announced that it will begin a phase 3 trial of the German CureVac vaccine against COVID-19.
